More articles from Molecular Targeting Probes-Radioactive & Nonradioactive - Radiopharmacy & Clinical Production

You have access
Cu-Mediated 18F-Fluorination of Arylboronic Acids: Supressing Protodeboronation towards Advanced PET Imaging Agents
Carolin Jaworski, Jingkai Sun, Dennis Hall and Ralf Schirrmacher

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 242485;
You have access
Assessment of the Radiochemical Purity and Chemical Identity of [225Ac]Ac-Labeled Radiotherapeutics by TLC and RP-HPLC
Anja Wacker, Shashi Ponnala and James Kelly

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 242479;
You have access
First in human study of 18F-FDOPA generated by photoredox radiofluorination
Li Wang, Zhiyu Lv, Xuedan Wu, Liping Yang, Wei Chen, Yan Zhu, Zhanhong Wu, Yue Chen and Zibo Li

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 241997;
You have access
A Fully Automated Synthesis of USP 823 Compliant [F-18]Fallypride on Sofie Elixys/Pure Form
Murthy Akula, Derek Cressy and Dustin Osborne

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 242302;
You have access
Utilizing HPLC to assess immunoreactivity of labeled biologics
Ashtyn McAdoo, Marisa Hom, Eben Rosenthal and Adam Rosenberg

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 242308;
You have access
Roadmap for the accelerated development and clinical translation of fluorescent tracers using adalimumab-680LT
Rosalie van Dijken, Henrik Huizinga, Bahez Gareb, Bart Dekkers, Coba van Zanten, Wouter Nagengast and Marjolijn Lub-de Hooge

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 242048;
You have access
In-house GMP manufacturing of [211At]PSMA-5 solution using an automated synthesizer for investigator-initiated clinical trials
Sadahiro Naka, Yoshifumi Shirakami, Naoya Jinno, Toshihiro Sakai, Kazuhiro Ooe, Kenta Kurimoto, Yukiyoshi Kon, Yin Xiaojie, Hiromitsu Haba, Atsushi Toyoshima and Tadashi Watabe

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 242337;
You have access
Radiolabelling of human mesenchymal and hematopoietic stem cells with [89Zr]Zr-Df-Bz-NCS for possible future stem cell therapy tracking with PET
Maryke Kahts, Juanita Mellet, Chrisna Durandt, Kinosha Moodley, Beverley Summers, Thomas Ebenhan, Jan Rijn Zeevaart, Omer Aras and Michael Pepper

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 242250;
You have access
A highly potent FAP-targeting peptide for theranostics: production, validation and first in human experience with Ga-68 and Lu-177 3BP-3940
Lukas Greifenstein, Annika Gunkel, Aileen Hoehne, Frank Osterkamp, Christiane Smerling, Christian Landvogt, Corinna Mueller and Richard P. Baum

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 242079;
You have access
Cyclotron Produced Gallium-68 to Manufacture Clinical Gallium-68 Tracers Without Commercial Kits
Ivan Wang, Kevin Cheng, Allen Brooks and Peter Scott

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 241587;

Main menu

User menu

Search

More articles from Molecular Targeting Probes-Radioactive & Nonradioactive - Radiopharmacy & Clinical Production

Pages